SynapDX is an early stage laboratory services company developing a blood based test to enable earlier detection of Autism Spectrum Disorders (ASDs), according to Stanley Lapidus, CEO. ASDs are characterized by impairment in language and socialization as well as restricted and repetitive behaviors. “They are doing some very exciting research,” said Dr. Frank Gagliardi, executive …

Read more EARLY AUTISM DETECTION RESEARCHER STANLEY LAPIDUS, CEO, OF SYNAPDX VISITED THE LEAGUE SCHOOL OF GREATER BOSTON RECENTLY